摘要
目的:探究奥美拉唑联合克拉霉素治疗慢性胃炎的临床疗效。方法:以2017年1月—12月为病例选取时间,纳入104例慢性胃炎患者,按照入院登记先后顺序分为参照组、研究组,各52例,分别予以奥美拉唑、奥美拉唑联合克拉霉素治疗,对比疗效。结果:研究组患者临床治疗总有效率为98.08%(51/52),明显高于参照组的86.54%(45/58),对比差异明显(P<0.05);研究组患者不良反应总发生率为5.77%(3/52),明显低于参照组的21.15%(11/52),对比差异明显(P<0.05)。结论:予以慢性胃炎患者奥美拉唑联合克拉霉素治疗,可提升临床治疗总有效率,减少不良反应,安全可靠,效果理想。
Objective:To explore the clinical efficacy of omeprazole combined with clarithromycin in the treatment of chronic gastritis.Methods:From January to December of 2017,104 patients with chronic gastritis were divided into a reference group and a study group with 52 patients in each group according to the order of admission.The effect of Omeprazole and omeprazole combined Clarithromycin were compared.Results:The total effective rate of clinical treatment in the study group was 98.08%(51/52),which was significantly higher than that in the reference group(86.54%,45/58).The difference was significant(P<0.05);the total incidence of adverse reactions in the study group It was 5.77%(3/52),which was significantly lower than 21.15%(11/52)in the reference group.The difference was significant(P<0.05).Conclusion:The treatment of omeprazole combined with clarithromycin in patients with chronic gastritis can improve the total efficiency of clinical treatment,reduce adverse reactions.It is safe and reliable,with ideal effect and application value.
作者
刘志勇
LIU Zhi-yong(Zhangshu Third People's Hospital,Zhangshu Jiangxi 331200,China)
出处
《药品评价》
CAS
2019年第2期31-33,62,共4页
Drug Evaluation
关键词
奥美拉唑
克拉霉素
慢性胃炎
Omeprazole
Clarithromycin
Chronic Gastritis